Trade Ideas
SpaceX is targeting a confidential IPO filing in March for a June listing, seeking a valuation potentially north of $1.75 trillion. This would be a generational market event. As the first "Mega-Cap" private tech firm to list in this cycle (beating OpenAI/Anthropic), it will command massive institutional demand. The valuation suggests it will be treated immediately as a "Mag-7" caliber asset. WATCH for the IPO filing confirmation; this is a must-own institutional staple upon listing. Regulatory delays with the SEC or valuation pushback if the $1.75T figure is deemed too rich.
"Does it create a vacuum? Is anyone else going to try to go public in June if Elon Musk is out there marketing this deal?" Capital is finite in the short term. A $1.75T asset listing sucks all the oxygen (capital and attention) out of the room. Any other company attempting to IPO in the June window will likely face a "capital strike" or be forced to price at a steep discount because bankers are focused entirely on SpaceX. AVOID non-SpaceX IPOs targeting a June listing. The market liquidity is deeper than expected and can absorb multiple deals.
SpaceX's timeline would "open the door for the company to beat out OpenAI and Anthropic to going public." First-mover advantage in the "Private Mega-Tech" asset class is critical. If SpaceX secures the bulk of available growth capital first, subsequent IPOs like OpenAI or Anthropic may face investor fatigue or tighter wallets. WATCH. This puts pressure on these firms to either accelerate their timelines or wait for capital reserves to replenish post-SpaceX. Investor appetite for AI/Space tech is insatiable, allowing all three to list successfully.
Bankers report that portfolio managers are saying, "I need to sell down a stake of Starbucks to create the capacity to buy this." Mega-IPOs act as liquidity drains. Asset managers rarely sit on billions in cash; they fund new massive allocations by selling liquid, widely-held "quality" stocks. SBUX is explicitly named as a source of funds, implying it (and similar large-caps) will face selling pressure as the SpaceX book builds. SHORT / AVOID in the lead-up to the SpaceX IPO due to rotation flows. SpaceX IPO is delayed, removing the immediate need for managers to sell SBUX.
This Bloomberg Markets video, published February 27, 2026,
features Bailey Lipschultz
discussing SPACEX, IPO, OPENAI, ANTHROPIC, SBUX.
4 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Bailey Lipschultz
· Tickers:
SPACEX,
IPO,
OPENAI,
ANTHROPIC,
SBUX